These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9635912

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Martín-Herrero JE.
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
    [Abstract] [Full Text] [Related]

  • 6. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J, Verbist L.
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [Abstract] [Full Text] [Related]

  • 7. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
    Fenoll A, Casal J, Giménez MJ, Jado I, Aguilar L.
    J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Gimeno M, Coronel P.
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [Abstract] [Full Text] [Related]

  • 9. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
    Boussougant Y, Weber P.
    Presse Med; 1989 Oct 11; 18(32):1553-5. PubMed ID: 2530530
    [Abstract] [Full Text] [Related]

  • 10. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
    Balcabao IP, Aguilar L, Martín M, García Y, Dal-Ré R, Prieto J.
    Antimicrob Agents Chemother; 1996 Dec 11; 40(12):2904-6. PubMed ID: 9124866
    [Abstract] [Full Text] [Related]

  • 11. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM, Rybak MJ.
    Antimicrob Agents Chemother; 1996 May 11; 40(5):1148-52. PubMed ID: 8723456
    [Abstract] [Full Text] [Related]

  • 12. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
    Hupková H, Trupl J.
    Folia Microbiol (Praha); 1998 May 11; 43(1):68-70. PubMed ID: 9569631
    [Abstract] [Full Text] [Related]

  • 13. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
    Murphy ME, Powell E, Courter J, Mortensen JE.
    BMC Infect Dis; 2021 Jul 13; 21(1):679. PubMed ID: 34256734
    [Abstract] [Full Text] [Related]

  • 14. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
    Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC.
    J Antimicrob Chemother; 1993 Feb 13; 31(2):273-80. PubMed ID: 8463172
    [Abstract] [Full Text] [Related]

  • 15. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
    Lin E, Stanek RJ, Mufson MA.
    Antimicrob Agents Chemother; 2003 Mar 13; 47(3):1151-3. PubMed ID: 12604560
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1994 Dec 13; 38(12):2902-4. PubMed ID: 7695280
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Dec 13; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
    Aguilar L, Rosendo J, Balcabao IP, Martín M, Giménez MJ, Frías J, Prieto J.
    Antimicrob Agents Chemother; 1997 Jun 13; 41(6):1389-91. PubMed ID: 9174206
    [Abstract] [Full Text] [Related]

  • 19. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N, Piroth L, Lequeu C, Neuwirth C, Portier H, Chavanet P.
    Antimicrob Agents Chemother; 2001 Dec 13; 45(12):3328-33. PubMed ID: 11709304
    [Abstract] [Full Text] [Related]

  • 20. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
    Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1996 Sep 13; 40(9):1973-6. PubMed ID: 8878565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.